Atezolizumab + bevacizumab in hepatocellular carcinoma (HCC): Safety and clinical activity results from a phase Ib study

Atezolizumab + bevacizumab in hepatocellular carcinoma (HCC): Safety and clinical activity results from a phase Ib study

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 29; p. ix47
Main Authors: Lee, K.-H., Hsu, C.-H., Lee, M.S., Ryoo, B.-Y., Verret, W., He, A.R., Kwan, A., Liu, B., Iizuka, K., Stein, S.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-11-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy432.002